false
Catalog
The Lead Episode 31: Efficacy and Safety of Hybrid ...
The Lancet
The Lancet
Back to course
Pdf Summary
A randomized controlled trial compared the efficacy and safety of hybrid epicardial-endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation (AF). The study enrolled 154 patients, with 102 receiving hybrid ablation and 52 receiving endocardial ablation. The primary effectiveness endpoint was freedom from AF/atrial flutter/atrial tachycardia through 12 months without the use of class I/III anti-arrhythmic drugs, and the results showed that hybrid ablation had a significantly higher effectiveness rate compared to endocardial ablation (71.6% vs 39.2%). The study also found that the hybrid ablation approach did not significantly increase the risk of major complications compared to endocardial ablation. The authors suggest that hybrid ablation, which combines both epicardial and endocardial ablation, may be a more effective treatment option for patients with persistent and longstanding persistent AF. However, further research is needed to confirm these findings and determine the long-term outcomes of the hybrid ablation approach.
Keywords
randomized controlled trial
hybrid epicardial-endocardial ablation
endocardial ablation
persistent atrial fibrillation
longstanding persistent atrial fibrillation
efficacy
safety
effectiveness endpoint
anti-arrhythmic drugs
major complications
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English